Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions (Q33980117)

30 July 2017

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions (English)

1 reference

30 July 2017

anti-retroviral agent

0 references

10

Daniel Podzamczer

1 reference

30 July 2017

8

Ard van Sighem

1 reference

30 July 2017

6

Caroline Sabin

0 references

Dominique Costagliola

23

object named as

Dominique Costagliola

1 reference

30 July 2017

21

Emilie Lanoy

1 reference

30 July 2017

José Ramón Arribas

12

0 references

François Dabis

16

object named as

François Dabis

1 reference

30 July 2017

1

Ellen C Caniglia

1 reference

30 July 2017

3

Amy Justice

1 reference

30 July 2017

7

Alan Winston

1 reference

30 July 2017

Lauren E Cain

2

1 reference

30 July 2017

Janet Tate

4

1 reference

30 July 2017

Roger Logan

5

1 reference

30 July 2017

Jose M Miro

9

1 reference

30 July 2017

Ashley Olson

11

1 reference

30 July 2017

Santiago Moreno

13

1 reference

30 July 2017

Laurence Meyer

14

1 reference

30 July 2017

Jorge del Romero

15

1 reference

30 July 2017

Heiner C Bucher

17

1 reference

30 July 2017

Gilles Wandeler

18

1 reference

30 July 2017

Georgia Vourli

19

1 reference

30 July 2017

Athanasios Skoutelis

20

1 reference

30 July 2017

Jacques Gasnault

22

1 reference

30 July 2017

Miguel A Hernán

24

1 reference

30 July 2017

HIV-CAUSAL Collaboration

25

1 reference

30 July 2017

language of work or name

English

0 references

publication date

6 June 2014

1 reference

30 July 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Neurology

1 reference

30 July 2017

83

1 reference

30 July 2017

2

1 reference

30 July 2017

134-141

1 reference

Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

An internationally generalizable risk index for mortality after one year of antiretroviral therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Antiretroviral neurotoxicity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Neurocognitive dysfunction in the highly active antiretroviral therapy era.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

HIV, antiretroviral therapies, and the brain

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Competing risk regression models for epidemiologic data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Increased accumulation of intraneuronal amyloid beta in HIV-infected patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Changing incidence of central nervous system diseases in the EuroSIDA cohort

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

Survival after neuroAIDS: Association with antiretroviral CNS Penetration-Effectiveness score

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4117168

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

10 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24907236

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/WNL.0000000000000564

1 reference

30 July 2017

1 reference

30 July 2017

1 reference